CEL-SCI raises $2.5M in common stock offering for Multikine development

CEL SCI CORP

2.5M shares sold at $1.00/share, gross proceeds $2.5M; offering closed June 16, 2026.
Proceeds to fund continued development of Multikine, general corporate purposes, and working capital.
ThinkEquity acted as placement agent; fee of 7% of gross proceeds plus up to $67K expense reimbursement.
Directors and officers subject to 45-day lock-up; company subject to 30-day lock-up on further issuance.
Offered under effective shelf registration (333-288515) with prospectus supplement filed June 14, 2026.

item 1.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

CEL SCI CORP entered into Placement Agency Agreement with ThinkEquity LLC valued at $2,500,000 (effective 2026-06-14).

Action: entry
Agreement: underwriting
Counterparty: ThinkEquity LLC
Value: $2,500,000
Effective: 2026-06-14

Exact text from the filing

On June 14, 2026, CEL-SCI Corporation, a Colorado corporation (the "Company"), entered into a Placement Agency Agreement with ThinkEquity LLC (the "Placement Agent") relating to the sale and issuance of 2,500,000 shares of the Company’s common stock, at an offering price of $1.00 per share (the "Shares").

View on SEC.gov

801 material agreements filed in the last 30 days. Browse all material agreements →

CEL SCI CORP filing history →

Source: SEC EDGAR

accession 0001654954-26-006015

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.